Internalized antigens must be removed to prepare hypoimmunogenic mesenchymal stem cells for cell and gene therapy.
about
Bioprocessing strategies for the large-scale production of human mesenchymal stem cells: a reviewMesenchymal stem/stromal cells: a new ''cells as drugs'' paradigm. Efficacy and critical aspects in cell therapyMesenchymal Stem Cells: Rising Concerns over Their Application in Treatment of Type One Diabetes MellitusOptimization of pre-transplantation conditions to enhance the efficacy of mesenchymal stem cellsIntraperitoneally infused human mesenchymal stem cells form aggregates with mouse immune cells and attach to peritoneal organs.A xenogeneic-free protocol for isolation and expansion of human adipose stem cells for clinical usesDonor age of human platelet lysate affects proliferation and differentiation of mesenchymal stem cellsHuman adipose stem cells maintain proliferative, synthetic and multipotential properties when suspension cultured as self-assembling spheroids.Collagen nanofibres are a biomimetic substrate for the serum-free osteogenic differentiation of human adipose stem cells.Adipose-derived stem cells for the regeneration of damaged tissues.Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD/scid mice.Stem cells and cell therapies in lung biology and lung diseasesDifferential gene expression in adipose stem cells cultured in allogeneic human serum versus fetal bovine serum.Human Bone Marrow Mesenchymal Stem/Stromal Cells Preserve Their Immunomodulatory and Chemotactic Properties When Expanded in a Human Plasma Derived Xeno-Free Medium.Towards a clinically relevant lentiviral transduction protocol for primary human CD34 hematopoietic stem/progenitor cells.Intravenous transplantation of mesenchymal stem cells preconditioned with early phase stroke serum: current evidence and study protocol for a randomized trial.Research Advancements in Porcine Derived Mesenchymal Stem Cells.Current status of cell therapies in stroke.Mesenchymal stem cells and tissue engineering.Standardization of platelet releasate products for clinical applications in cell therapy: a mathematical approachComparison of human adult stem cells from adipose tissue and bone marrow in the treatment of experimental autoimmune encephalomyelitis.Thrombin promotes fibronectin secretion by bone marrow mesenchymal stem cells via the protease-activated receptor mediated signalling pathways.Ex vivo expansion of bovine corneal endothelial cells in xeno-free medium supplemented with platelet releasateSafety and Feasibility of Autologous Mesenchymal Stem Cell Transplantation in Chronic Stroke in Indian patients. A four-year follow upThree-dimensional culture using human plasma-medium gel with fragmin/protamine microparticles for proliferation of various human cellsDifferent culture conditions modulate the immunological properties of adipose stem cells.Unique characteristics of human mesenchymal stromal/progenitor cells pre-activated in 3-dimensional cultures under different conditions.Stem cell-based treatments against stroke: observations from human proof-of-concept studies and considerations regarding clinical applicability.Mesenchymal stem or stromal cells: a review of clinical applications and manufacturing practices.In vivo tumorigenesis was observed after injection of in vitro expanded neural crest stem cells isolated from adult bone marrowSafety of cell therapy with mesenchymal stromal cells (SafeCell): a systematic review and meta-analysis of clinical trials.Histone deacetylase inhibition destabilizes the multi-potent state of uncommitted adipose-derived mesenchymal stromal cellsHuman serum promotes osteogenic differentiation of human dental pulp stem cells in vitro and in vivo.MSCs conditioned media and umbilical cord blood plasma metabolomics and composition.Derivation of iPSCs after culture of human dental pulp cells under defined conditions.Human bone marrow-derived mesenchymal stem cells.Aggregation of Human Eyelid Adipose-derived Stem Cells by Human Body Fluids.Intravenous administration of auto serum-expanded autologous mesenchymal stem cells in stroke.Selection of osteoprogenitors from the jaw periosteum by a specific animal-free culture mediumMesenchymal stromal cell proliferation, gene expression and protein production in human platelet-rich plasma-supplemented media
P2860
Q26776414-BC5DBC9F-6B7F-4993-A60A-A1A658038D5BQ26825272-E4260702-D70D-4526-B8D9-6B77D22407DBQ26864580-87AD1F69-E81B-4D67-9174-44279536B5A2Q27015774-F3923611-408D-4A05-9D31-DB819577956DQ27322349-8DF4F312-10AD-4AA5-81DA-67EF02A2E28BQ28534582-672B77D0-376D-4EA9-A058-D30205EC75BEQ28729211-37DDC7B5-4083-4808-BC0F-0DD92B619E01Q30418982-F45659BB-C7FF-4A4C-8B8C-A3F933BC91ECQ30431781-6D11C0CF-3884-416F-8B73-739B99629416Q30440478-C1AE64EA-287F-4D42-B30C-603D4DB98A41Q30478228-AEA25FC7-DD69-496F-BB06-1CD043C20815Q30486086-31A48E3C-C2E0-4312-BE85-0ACCAA698E1BQ30496289-B391E7DD-1930-4E80-948A-98269292A104Q30853758-BC624E9D-F348-412A-B0F8-1B1CC501D3BAQ33489590-CB13E929-D510-436F-B0CA-DF0803C58A8EQ33592708-9625CFBF-085F-4407-8D5C-14CA6A3149C6Q33600383-A3902DCD-AEE9-46D8-8100-1331E12282CBQ33614825-B49D8434-910C-491C-A646-7753DD67277BQ33668967-397FFC0A-E12A-46B8-9F65-C20CCF1EF292Q33706611-65A3E163-808D-45CF-B673-1543B9C57FDAQ33745926-7462B826-DD0E-49E9-A8F8-4A13EDBBCEB7Q33746604-98836D56-105F-4F30-88F5-E6F11D012BA9Q33778870-05924C53-EE33-4067-A349-F55A26C0B361Q33863334-FF7863CD-1E31-4F60-AB60-D26DC79C8834Q34150797-38ED79DD-454C-4BF1-867E-04AE2FD111A9Q34273076-00C308E3-BACC-4226-9B70-ABA334003FAAQ34307885-5CDD664A-B471-4F16-9183-3CDF8BCDB199Q34419548-8C65EFC5-D524-4CFB-BE62-3C2C6482EC4EQ34422955-9E321CF4-1705-4D64-8DD4-5F72E3DC1D3BQ34447136-EAD187BB-01D0-4866-B003-6581A57360D3Q34469147-2AC71127-1BF0-4B52-9BA8-6C0B728FB2BAQ34475885-1885867C-E8E5-412B-B076-5B5CBF5973FDQ34500457-2B303921-B7C9-44F2-BE23-63593B39F479Q34572206-FCECDD83-8E31-4264-AF39-FA5050C125E6Q34734163-AB8122B0-6645-46F5-93BD-1DB4A4776994Q34803950-E1DC0DAE-EFC8-440E-8EB5-2B551BDBC487Q34804452-D9C0323C-E8CA-44A8-BE3E-F14202006DC3Q35007847-3EF263EA-D5B7-4D75-A4A4-1D9113BD83D0Q35069705-CE5F7F1E-D5BA-4DF3-B844-F2F09764FC54Q35223448-D442A9C1-F354-4F4F-A061-0281F68C0D20
P2860
Internalized antigens must be removed to prepare hypoimmunogenic mesenchymal stem cells for cell and gene therapy.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Internalized antigens must be ...... lls for cell and gene therapy.
@en
Internalized antigens must be ...... lls for cell and gene therapy.
@nl
type
label
Internalized antigens must be ...... lls for cell and gene therapy.
@en
Internalized antigens must be ...... lls for cell and gene therapy.
@nl
prefLabel
Internalized antigens must be ...... lls for cell and gene therapy.
@en
Internalized antigens must be ...... lls for cell and gene therapy.
@nl
P2093
P1433
P1476
Internalized antigens must be ...... lls for cell and gene therapy.
@en
P2093
Alexandra Peister
H Alan Tucker
Harpreet Singh
Jason Smith
Jeffrey L Spees
Patrick J Lynch
Shu-Ching Hsu
P304
P356
10.1016/J.YMTHE.2004.02.012
P577
2004-05-01T00:00:00Z